InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-0.5%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Leibowitz Arthur S, Directeur. Officer active across 1 company, notably Organogenesis Holdings Inc.. Aggregated, 8 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €25k. History available since 3 August 2021. The latest transaction was disclosed on 9 March 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations8 total
5,000 shares@ US$2.681Class A Common StockSEC:0002064832-26-000129:0
Ideal exit: 4 Dec 2026 (T+270)
48,828 shares0Class A Common StockSEC:0002064832-26-000054:0
49,575 shares0Class A Common StockSEC:0001062993-25-003217:0
51,020 shares0Class A Common StockSEC:0001062993-24-004306:0
65,737 shares0Class A Common StockSEC:0001062993-23-004881:0
3,000 shares@ US$4.755100.0% of flowClass A Common StockSEC:0001062993-22-018040:0
Ideal exit: 9 May 2023 (T+270)
20,547 shares0Class A Common StockSEC:0001062993-22-004806:0
5,000 shares0Class A Common StockSEC:0001661181-21-000064:0
8 of 8 declarations
About Leibowitz Arthur S
Arthur S. Leibowitz is a Director at Organogenesis Holdings Inc. He contributes to the governance of the company by participating in strategic decisions and overseeing operations. His experience in the healthcare sector allows him to provide valuable insights for the development and growth of the company.
